Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease

Mass spectrometry-based metabolomics has undergone significant progresses in the past decade, with a variety of software packages being developed for data analysis. However, systematic comparison of different metabolomics software tools has rarely been conducted. In this study, several representative software packages were comparatively evaluated throughout the entire pipeline of metabolomics data analysis, including data processing, statistical analysis, feature selection, metabolite identification, pathway analysis, and classification model construction. LC-MS-based metabolomics was applied to preclinical Alzheimer’s disease (AD) using a small cohort of human cerebrospinal fluid (CSF) samples (N = 30). All three software packages, XCMS Online, SIEVE, and Compound Discoverer, provided consistent and reproducible data processing results. A hybrid method combining statistical test and support vector machine feature selection was employed to screen key metabolites, achieving a complementary selection of candidate biomarkers from three software packages. Machine learning classification using candidate biomarkers generated highly accurate and predictive models to classify patients into preclinical AD or control category. Overall, our study demonstrated a systematic evaluation of different MS-based metabolomics software packages for the entire data analysis pipeline which was applied to the candidate biomarker discovery of preclinical AD.

[1]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[2]  Lingjun Li,et al.  Investigation of signaling molecules and metabolites found in crustacean hemolymph via in vivo microdialysis using a multifaceted mass spectrometric platform , 2016, Electrophoresis.

[3]  Kyoungmi Kim,et al.  Metabolomics in the study of kidney diseases , 2012, Nature Reviews Nephrology.

[4]  D. Pawlak,et al.  Kynurenine and its metabolites in Alzheimer's disease patients. , 2010, Advances in medical sciences.

[5]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[6]  Laxman Yetukuri,et al.  Algorithms and tools for the preprocessing of LC–MS metabolomics data , 2011 .

[7]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[8]  G. Siuzdak,et al.  XCMS Online: a web-based platform to process untargeted metabolomic data. , 2012, Analytical chemistry.

[9]  Lingjun Li,et al.  Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS. , 2015, The Analyst.

[10]  Ronald C. Petersen,et al.  Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics , 2013, PloS one.

[11]  Richard D. Smith Mass spectrometry in biomarker applications: from untargeted discovery to targeted verification, and implications for platform convergence and clinical application. , 2012, Clinical chemistry.

[12]  D. Wishart,et al.  The human cerebrospinal fluid metabolome. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[14]  Masaru Tomita,et al.  Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis , 2012, Current bioinformatics.

[15]  Adam P. Arkin,et al.  Interactive XCMS Online: Simplifying Advanced Metabolomic Data Processing and Subsequent Statistical Analyses , 2014, Analytical chemistry.

[16]  Hong Wang,et al.  Glutathione Metabolism during Aging and in Alzheimer Disease , 2004, Annals of the New York Academy of Sciences.

[17]  Sirish L. Shah,et al.  Analysis of metabolomic data using support vector machines. , 2008, Analytical chemistry.

[18]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[19]  O. Okonkwo,et al.  Label‐free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals , 2016, Proteomics. Clinical applications.

[20]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[21]  Haifang Li,et al.  Fractional factorial design based microwave-assisted extraction for the determination of organophosphorus and organochlorine residues in tobacco by using gas chromatography-mass spectrometry. , 2017, Journal of separation science.

[22]  Alexander G. Gray,et al.  Highly-accurate metabolomic detection of early-stage ovarian cancer , 2015, Scientific Reports.

[23]  F. Fernández,et al.  Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study. , 2017, Journal of proteome research.

[24]  R. Cotter,et al.  Mass Spectrometry , 1992, Bio/Technology.

[25]  B. Solomon Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease. , 2001, DNA and cell biology.

[26]  D. Muddiman,et al.  Compartment proteomics analysis of white perch (Morone americana) ovary using support vector machines. , 2014, Journal of proteome research.

[27]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[28]  P. Marker,et al.  In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms , 2016, Scientific Reports.

[29]  F. Panza,et al.  Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. , 2011, Progress in lipid research.

[30]  Matej Oresic,et al.  MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data , 2010, BMC Bioinformatics.

[31]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[32]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[33]  Ian J Deary,et al.  Homocysteine, B vitamin status, and cognitive function in the elderly. , 2002, The American journal of clinical nutrition.

[34]  Jianfeng Lu,et al.  Quantitative analysis of serotonin secreted by human embryonic stem cells‐derived serotonergic neurons via pH‐mediated online stacking‐CE‐ESI‐MRM , 2016, Electrophoresis.

[35]  Loris Nanni,et al.  Advanced machine learning techniques for microarray spot quality classification , 2010, Neural Computing and Applications.

[36]  Suxia Han,et al.  fied, along with their associated protein‐protein interaction networks and Kyoto Encyclopedia of Genes and Genomes , 2019 .

[37]  John L Markley,et al.  Metabolite identification via the Madison Metabolomics Consortium Database , 2008, Nature Biotechnology.

[38]  Arjen Lommen,et al.  MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. , 2009, Analytical chemistry.

[39]  Eoin Fahy,et al.  LIPID MAPS online tools for lipid research , 2007, Nucleic Acids Res..

[40]  Oliver Fiehn,et al.  A new metabolomic workflow for early detection of Alzheimer's disease. , 2013, Journal of chromatography. A.

[41]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[42]  Lingjun Li,et al.  Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells. , 2017, Analytical chemistry.

[43]  W. Xu,et al.  Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. , 2014, Journal of proteome research.

[44]  David C Muddiman,et al.  Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality. , 2009, Annual review of analytical chemistry.

[45]  Monica Chagoyen,et al.  MBROLE 2.0—functional enrichment of chemical compounds , 2016, Nucleic Acids Res..

[46]  I. Ong,et al.  PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis , 2017, Nature Cell Biology.

[47]  R. Kennedy,et al.  Negative mode sheathless capillary electrophoresis electrospray ionization-mass spectrometry for metabolite analysis of prokaryotes. , 2006, Journal of chromatography. A.

[48]  Joshua D Rabinowitz,et al.  Metabolomic analysis and visualization engine for LC-MS data. , 2010, Analytical chemistry.

[49]  J. Pintor,et al.  The neurotransmitter role of diadenosine polyphosphates , 1998, FEBS letters.

[50]  Gilles J. Guillemin,et al.  Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases , 2017, Neuropharmacology.

[51]  J. Gómez-Ariza,et al.  Using direct infusion mass spectrometry for serum metabolomics in Alzheimer’s disease , 2014, Analytical and Bioanalytical Chemistry.

[52]  Oscar Yanes,et al.  Metabolomics: the apogee of the omics trilogy , 2012 .

[53]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[54]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[55]  Xianlin Han,et al.  Metabolomic changes in autopsy-confirmed Alzheimer's disease , 2011, Alzheimer's & Dementia.

[56]  David S. Wishart,et al.  MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..

[57]  Matthias Müller-Hannemann,et al.  In silico fragmentation for computer assisted identification of metabolite mass spectra , 2010, BMC Bioinformatics.

[58]  C. Barbas,et al.  Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis–mass spectrometry , 2014, Electrophoresis.

[59]  F. Bamforth,et al.  Qualitative Metabolome Analysis of Human Cerebrospinal Fluid by 13C-/12C-Isotope Dansylation Labeling Combined with Liquid Chromatography Fourier Transform Ion Cyclotron Resonance Mass Spectrometry , 2011, Journal of the American Society for Mass Spectrometry.